Skip to content
OpenCapital
Get started

Catalyst Pharmaceutical CPRX Fycompa — Revenue

Other product segments

Product Revenue Net
$149.34M+5.6%
Firdapse
$98.86M+18.1%
Agamree
$36.71M+66.6%

Similar metrics at other companies

Biogen logo
BIIBFAMPYRA — Total Revenue
$0-100%
LQD
LQDAProduct — Revenue
$129.88M—
Lantheus Holdings logo
LNTHPYLARIFY — Revenue
$240.92M-6.5%
Axsome Therapeutics logo
AXSMProduct — Revenue
$189.4M+57.4%
Alkermes logo
ALKSProduct — Revenue
$338.11M+38.3%
Ionis Pharmaceuticals logo
IONSCommercial — Revenue
$107.81M+41.5%

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K—
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%
Enterprise value$3.09B-4.1%
P/E17.4×-1.6×
P/S6.4×-0.6×

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0×0.0×
Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's fycompa — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's fycompa — revenue?
Catalyst Pharmaceutical (CPRX) reported fycompa — revenue of $13.77M in Q1 2026.
How has Catalyst Pharmaceutical's fycompa — revenue changed year-over-year?
Catalyst Pharmaceutical's fycompa — revenue decreased by 61.3% year-over-year, from $35.63M to $13.77M.
What does fycompa — revenue mean?
This metric represents the total net sales generated from the commercialization of the Fycompa product line, excluding any taxes collected from customers. It serves as a key indicator of the product's market adoption, pricing power, and contribution to the company's overall top-line performance. Monitoring this revenue stream helps investors evaluate the commercial success and growth trajectory of this specific therapeutic asset within the company's portfolio.